Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Study reveals how fast weight returns after ending GLP-1 drugs - 2Viable Monetary Tips to Advance Your Monetary Circumstance
- 3Elite Execution Wall televisions for Film Darlings
- 4Shas threatens to oppose 2026 state budget over haredi food-voucher exclusion
- 5Syria rejects forced deportations from Germany amid migration debate
- Get To Be familiar with The Historical backdrop Of Western Medication
- Rescuers attempt to dig free whale stranded on Germany's Baltic coast
- Step by step instructions to Guarantee the Strength and Life span of Your Pre-assembled Home
- Find the Native Culinary Customs: Local Flavors
- Most loved Seared Chicken: Which Chain Rules?
- Investigate Something else for Less: Financial plan Travel Objections
- Vote in favor of your Number one kind of juice
- Can humans have babies in space? It may be harder than expected
- Canada cancels its 1st moon rover: 'It's hopefully not a lost cause'
